Bafna Pharmaceuticals has informed that it enclosed certificate from Practicing Company Secretary under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the half year ended 31st March 2022.
The above information is a part of company’s filings submitted to BSE.